Large-scale generation of human allodepleted anti-3rd party lymphocytes.

[1]  A. Poggi,et al.  Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. , 2007, Haematologica.

[2]  J. Storek,et al.  Immune reconstitution following hematopoietic stem-cell transplantation. , 2007, Best practice & research. Clinical haematology.

[3]  Mark S. Sundrud,et al.  New twists of T cell fate: control of T cell activation and tolerance by TGF-beta and NFAT. , 2007, Current opinion in immunology.

[4]  R. Lechler,et al.  Allorecognition and the alloresponse: clinical implications. , 2007, Tissue antigens.

[5]  P. Puccetti.  On watching the watchers: IDO and type I/II IFN , 2007, European journal of immunology.

[6]  M. Battaglia,et al.  Erratum: Interleukin-10- secreting type 1 regulatory T cells in rodents and humans (Immunological Reviews (2006) 212, (28-50)) , 2006 .

[7]  R. Krance,et al.  Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. , 2006, Blood.

[8]  Katharina Fleischhauer,et al.  Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans , 2006, Immunological reviews.

[9]  E. Aandahl,et al.  FOXP3+CD4+CD25+ Adaptive Regulatory T Cells Express Cyclooxygenase-2 and Suppress Effector T Cells by a Prostaglandin E2-Dependent Mechanism1 , 2006, The Journal of Immunology.

[10]  H. Messner.  How good is allogeneic transplantation for high-risk patients with AML? , 2006, Best practice & research. Clinical haematology.

[11]  W. Zou.  Regulatory T cells, tumour immunity and immunotherapy , 2006, Nature Reviews Immunology.

[12]  A. Tosti,et al.  Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. , 2005, Blood.

[13]  M. Martelli,et al.  Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation. , 2005, Human immunology.

[14]  C. Mecucci,et al.  Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Berrebi,et al.  Eradication of B-CLL by autologous and allogeneic host nonreactive anti-third-party CTLs. , 2005, Blood.

[16]  S. Sakaguchi.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.

[17]  S. Reich-Zeliger,et al.  Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose. , 2003, Blood.

[18]  P. Romero,et al.  Retrovirus-mediated gene transfer in polyclonal T cells results in lower apoptosis and enhanced ex vivo cell expansion of CMV-reactive CD8 T cells as compared with EBV-reactive CD8 T cells. , 2003, Blood.

[19]  A. Nagler,et al.  Hematopoietic stem-cell transplantation using umbilical-cord blood. , 2003, Leukemia & lymphoma.

[20]  J. Kurtzberg,et al.  Coexistent naïve phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. , 2003, Experimental hematology.

[21]  A. Fischer,et al.  Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study , 2002, The Lancet.

[22]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.

[23]  B. Blazar,et al.  The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. , 2002, Blood.

[24]  J. Melo,et al.  Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms. , 2002, Blood.

[25]  T. Klingebiel,et al.  OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants. , 2000 .

[26]  J. Gribben,et al.  Transplantation of anergic histoincompatible bone marrow allografts. , 1999, The New England journal of medicine.

[27]  P. Gregersen,et al.  Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals. , 1998, Journal of immunology.

[28]  Ethan M. Shevach,et al.  CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.

[29]  C. Bordignon,et al.  HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. , 1997, Science.

[30]  H. Grosse-wilde,et al.  Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. , 1996, Blood.

[31]  J. Gribben,et al.  Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool. , 1996, Blood.

[32]  M. Yassai,et al.  Improvements in Repertoire Analysis by CDR3 Size Spectratyping , 1995, Annals of the New York Academy of Sciences.

[33]  M. Martelli,et al.  Transplants across human leukocyte antigen barriers. , 2002, Seminars in hematology.

[34]  S. Hacein-Bey,et al.  Greffe de moelle osseuse T déplétée HLA non géno-identique chez l’enfant : prévention de la réaction du greffon contre l’hôte par adjonction de lymphocytes T du donneur dépourvus d’alloréactivité vis-à-vis du receveur , 2001 .

[35]  D. Neuberg,et al.  Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. , 2000, Blood.